An International Research
Consortium to Maximise
Benefits & Equity of HIV
Treatment & Care Systems

University College London (UCL), and Medical Research Council Clinical Trials Unit, based in UK. The UCL group, which includes the MRC Clinical Trials Unit (CTU), has clinical, laboratory, statistical and training expertise. The group has a strong track record in evaluating strategies for the treatment of HIV infection in both adults and children in Europe and in Africa, as well as in leading large collaborations including capacity building in research and clinical practice in Africa. It is also a leader in the application of HIV resistance measurements to the evaluation of HIV treatment programmes (in collaboration with UK Health Protection Agency).

Institutional Consortium Co-leaders: Prof. Ian Weller and Dr. Kholoud Porter.